STEVEN LLOYD SOIGNET, MD
Osteopathic Medicine in New York, NY
License number
New York NY 199646
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
55 Broad St. SUITE 1840, New York, NY 10004
Phone
(212) 785-2236
(212) 785-2237 (Fax)
(212) 785-2237 (Fax)
Personal information
See more information about STEVEN LLOYD SOIGNET at radaris.comName
Address
Phone
2 Tudor City Pl APT 15DN, New York, NY 10017
New York, NY
2 Tudor City Pl, New York, NY 10017
303 60Th St, New York, NY 10022
561 10 Ave, New York, NY 10036
Professional information
Founding/ General Partner At Arcus Ventures
Location:
Greater New York City Area
Industry:
Financial Services
Experience:
Arcus Ventures (Financial Services industry): Founding/ General Partner, (October 2007-Present) Venture Capital Fund investing in Oncology focused companiesArcus Group (Financial Services industry): Founding Partner, (September 2001-September 2007) Con...
Dr. Steven L Soignet, New York NY - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
60 E 42Nd St SUITE 1610, New York 10165
Certifications:
Internal Medicine, 2006, Medical Oncology, 2009
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Louisiana State University / School of Medicine In New Orleans
Graduated: 1992
Vanderbilt Med Ctr
Memorial Sloan-Kettering Cancer Center
Louisiana State University / School of Medicine In New Orleans
Graduated: 1992
Vanderbilt Med Ctr
Memorial Sloan-Kettering Cancer Center
Process For Producing Arsenic Trioxide Formulations And Methods For Treating Cancer Using Arsenic Trioxide Or Melarsoprol
US Patent:
2003009, May 29, 2003
Filed:
Sep 30, 2002
Appl. No.:
10/259950
Inventors:
Raymond Warrell - Westfield NJ, US
Pier Pandolfi - New York NY, US
Janice Gabrilove - New York NY, US
Ralph Ellison - Palm Beach FL, US
Steven Soignet - New York NY, US
Pier Pandolfi - New York NY, US
Janice Gabrilove - New York NY, US
Ralph Ellison - Palm Beach FL, US
Steven Soignet - New York NY, US
Assignee:
Memorial Sloan-Kettering Cancer Center Cell Therapeutics, Inc.
International Classification:
A61K033/36
US Classification:
424/623000
Abstract:
The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.
Process For Producing Arsenic Trioxide Formulations And Methods For Treating Cancer Using Arsenic Trioxide Or Melarsoprol
US Patent:
2003021, Nov 13, 2003
Filed:
Apr 30, 2003
Appl. No.:
10/425785
Inventors:
Raymond Warrell - Wetsfield NJ, US
Pier Pandolfi - New York NY, US
Janice Gabrilove - New York NY, US
Ralph Ellison - Palm Beach FL, US
Steven Soignet - New York NY, US
Pier Pandolfi - New York NY, US
Janice Gabrilove - New York NY, US
Ralph Ellison - Palm Beach FL, US
Steven Soignet - New York NY, US
Assignee:
Memorial Sloan-Kettering Cancer Center
International Classification:
A61K033/36, A61K031/203
US Classification:
424/623000, 514/559000
Abstract:
The invention relates to the use of arsenic compounds to treat a variety of leukemia, lymphoma and solid tumors. Further, the arsenic compounds may be used in combination with other therapeutic agents, such as a retinoid. The invention also provides a process for producing arsenic trioxide formulations.